位置:首页 > 蛋白库 > NECT3_HUMAN
NECT3_HUMAN
ID   NECT3_HUMAN             Reviewed;         549 AA.
AC   Q9NQS3; E9PFR0; Q6NVZ3; Q8NC05; Q8WVU4; Q9BVA9; Q9Y412;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   03-AUG-2022, entry version 166.
DE   RecName: Full=Nectin-3;
DE   AltName: Full=CDw113;
DE   AltName: Full=Nectin cell adhesion molecule 3 {ECO:0000312|HGNC:HGNC:17664};
DE   AltName: Full=Poliovirus receptor-related protein 3;
DE   AltName: CD_antigen=CD113;
DE   Flags: Precursor;
GN   Name=NECTIN3 {ECO:0000312|HGNC:HGNC:17664}; Synonyms=PRR3, PVRL3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND INTERACTION
RP   WITH AFDN.
RX   PubMed=11024295; DOI=10.1016/s0378-1119(00)00316-4;
RA   Reymond N., Borg J.-P., Lecocq E., Adelaide J., Campadelli-Fiume G.,
RA   Dubreuil P., Lopez M.;
RT   "Human nectin3/PRR3: a novel member of the PVR/PRR/nectin family that
RT   interacts with afadin.";
RL   Gene 255:347-355(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 246-549 (ISOFORM 1).
RC   TISSUE=Brain, Cervix, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 143-549 (ISOFORM 1).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   INTERACTION WITH PVR.
RX   PubMed=12759359; DOI=10.1074/jbc.m304166200;
RA   Mueller S., Wimmer E.;
RT   "Recruitment of nectin-3 to cell-cell junctions through trans-heterophilic
RT   interaction with CD155, a vitronectin and poliovirus receptor that
RT   localizes to alpha(v)beta3 integrin-containing membrane microdomains.";
RL   J. Biol. Chem. 278:31251-31260(2003).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH PVR.
RX   PubMed=16216929; DOI=10.1083/jcb.200501090;
RA   Fujito T., Ikeda W., Kakunaga S., Minami Y., Kajita M., Sakamoto Y.,
RA   Monden M., Takai Y.;
RT   "Inhibition of cell movement and proliferation by cell-cell contact-induced
RT   interaction of Necl-5 with nectin-3.";
RL   J. Cell Biol. 171:165-173(2005).
RN   [8]
RP   INTERACTION WITH TIGIT.
RX   PubMed=19011627; DOI=10.1038/ni.1674;
RA   Yu X., Harden K., Gonzalez L.C., Francesco M., Chiang E., Irving B.,
RA   Tom I., Ivelja S., Refino C.J., Clark H., Eaton D., Grogan J.L.;
RT   "The surface protein TIGIT suppresses T cell activation by promoting the
RT   generation of mature immunoregulatory dendritic cells.";
RL   Nat. Immunol. 10:48-57(2009).
RN   [9]
RP   INTERACTION WITH C.DIFFICILE TCDB (MICROBIAL INFECTION), AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=26038560; DOI=10.1073/pnas.1500791112;
RA   LaFrance M.E., Farrow M.A., Chandrasekaran R., Sheng J., Rubin D.H.,
RA   Lacy D.B.;
RT   "Identification of an epithelial cell receptor responsible for Clostridium
RT   difficile TcdB-induced cytotoxicity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:7073-7078(2015).
RN   [10]
RP   INTERACTION WITH C.DIFFICILE TCDB (MICROBIAL INFECTION).
RX   PubMed=27680706; DOI=10.1038/nature19799;
RA   Tao L., Zhang J., Meraner P., Tovaglieri A., Wu X., Gerhard R., Zhang X.,
RA   Stallcup W.B., Miao J., He X., Hurdle J.G., Breault D.T., Brass A.L.,
RA   Dong M.;
RT   "Frizzled proteins are colonic epithelial receptors for C. difficile toxin
RT   B.";
RL   Nature 538:350-355(2016).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.93 ANGSTROMS) OF 58-359, SUBUNIT, GLYCOSYLATION AT
RP   ASN-73; ASN-125; ASN-186; ASN-222 AND ASN-331, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=22902367; DOI=10.1038/nsmb.2366;
RA   Harrison O.J., Vendome J., Brasch J., Jin X., Hong S., Katsamba P.S.,
RA   Ahlsen G., Troyanovsky R.B., Troyanovsky S.M., Honig B., Shapiro L.;
RT   "Nectin ectodomain structures reveal a canonical adhesive interface.";
RL   Nat. Struct. Mol. Biol. 19:906-915(2012).
CC   -!- FUNCTION: Plays a role in cell-cell adhesion through heterophilic
CC       trans-interactions with nectin-like proteins or nectins, such as trans-
CC       interaction with NECTIN2 at Sertoli-spermatid junctions. Trans-
CC       interaction with PVR induces activation of CDC42 and RAC small G
CC       proteins through common signaling molecules such as SRC and RAP1. Also
CC       involved in the formation of cell-cell junctions, including adherens
CC       junctions and synapses. Induces endocytosis-mediated down-regulation of
CC       PVR from the cell surface, resulting in reduction of cell movement and
CC       proliferation. Plays a role in the morphology of the ciliary body.
CC       {ECO:0000269|PubMed:16216929}.
CC   -!- SUBUNIT: Cis- and trans-homodimer. Can form trans-heterodimers with
CC       NECTIN1, NECTIN2, PVR, IGSF4B/Necl-1 and with IGSF4. Interaction
CC       between NECTIN1 and NECTIN3 on the pre- and postsynaptic sites,
CC       respectively, initiates the formation of puncta adherentia junctions
CC       between axons and dendrites. Interacts (via Cytoplasmic domain) with
CC       AFDN, providing a connection with the actin cytoskeleton. Binds with
CC       low affinity to TIGIT. {ECO:0000269|PubMed:11024295,
CC       ECO:0000269|PubMed:12759359, ECO:0000269|PubMed:16216929,
CC       ECO:0000269|PubMed:19011627, ECO:0000269|PubMed:22902367}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with C.difficile toxin TcdB,
CC       suggesting that it may contribute to TcdB toxin entry into cells
CC       (PubMed:26038560). It was however shown that NECTIN3/PVRL3 does not act
CC       as a major receptor for TcdB (PubMed:27680706).
CC       {ECO:0000269|PubMed:26038560, ECO:0000269|PubMed:27680706}.
CC   -!- INTERACTION:
CC       Q9NQS3; P21333-2: FLNA; NbExp=3; IntAct=EBI-2826725, EBI-9641086;
CC       Q9NQS3; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-2826725, EBI-10172290;
CC       Q9NQS3; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-2826725, EBI-10171774;
CC       Q9NQS3; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-2826725, EBI-10172052;
CC       Q9NQS3; Q9BYR5: KRTAP4-2; NbExp=3; IntAct=EBI-2826725, EBI-10172511;
CC       Q9NQS3; Q15223: NECTIN1; NbExp=2; IntAct=EBI-2826725, EBI-1771314;
CC       Q9NQS3; Q92692: NECTIN2; NbExp=3; IntAct=EBI-2826725, EBI-718419;
CC       Q9NQS3; Q7Z3S9: NOTCH2NLA; NbExp=4; IntAct=EBI-2826725, EBI-945833;
CC       Q9NQS3; O76081: RGS20; NbExp=3; IntAct=EBI-2826725, EBI-1052678;
CC       Q9NQS3; Q495A1: TIGIT; NbExp=2; IntAct=EBI-2826725, EBI-4314807;
CC       Q9NQS3-1; Q15223: NECTIN1; NbExp=3; IntAct=EBI-16007706, EBI-1771314;
CC       Q9NQS3-1; Q92692: NECTIN2; NbExp=2; IntAct=EBI-16007706, EBI-718419;
CC       Q9NQS3-1; Q9NQS3-1: NECTIN3; NbExp=3; IntAct=EBI-16007706, EBI-16007706;
CC       Q9NQS3-2; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-12106440, EBI-3867333;
CC       Q9NQS3-2; Q07627: KRTAP1-1; NbExp=3; IntAct=EBI-12106440, EBI-11959885;
CC       Q9NQS3-2; Q8IUG1: KRTAP1-3; NbExp=3; IntAct=EBI-12106440, EBI-11749135;
CC       Q9NQS3-2; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-12106440, EBI-10171774;
CC       Q9NQS3-2; A0A087WY89: KRTAP4-1; NbExp=3; IntAct=EBI-12106440, EBI-11957260;
CC       Q9NQS3-2; Q6L8G4: KRTAP5-11; NbExp=3; IntAct=EBI-12106440, EBI-11993296;
CC       Q9NQS3-2; P26371: KRTAP5-9; NbExp=3; IntAct=EBI-12106440, EBI-3958099;
CC       Q9NQS3-2; Q9BYQ3: KRTAP9-3; NbExp=3; IntAct=EBI-12106440, EBI-1043191;
CC       Q9NQS3-2; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-12106440, EBI-22310682;
CC       Q9NQS3-2; P32242: OTX1; NbExp=3; IntAct=EBI-12106440, EBI-740446;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26038560};
CC       Single-pass membrane protein {ECO:0000255}. Postsynaptic cell membrane
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NQS3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NQS3-2; Sequence=VSP_017435, VSP_017436;
CC       Name=3;
CC         IsoId=Q9NQS3-3; Sequence=VSP_046893, VSP_046894;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in testis and placenta as
CC       well as in many cell lines, including epithelial cell lines.
CC       {ECO:0000269|PubMed:11024295}.
CC   -!- SIMILARITY: Belongs to the nectin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION: [Isoform 1]:
CC       Sequence=AAH17572.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- SEQUENCE CAUTION: [Isoform 3]:
CC       Sequence=BAC11404.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF282874; AAF97597.1; -; mRNA.
DR   EMBL; AK075105; BAC11404.1; ALT_TERM; mRNA.
DR   EMBL; AC133436; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC133477; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC137833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001336; AAH01336.1; -; mRNA.
DR   EMBL; BC017572; AAH17572.1; ALT_INIT; mRNA.
DR   EMBL; BC067808; AAH67808.1; -; mRNA.
DR   EMBL; AL050071; CAB43256.1; -; mRNA.
DR   CCDS; CCDS2957.1; -. [Q9NQS3-1]
DR   CCDS; CCDS58842.1; -. [Q9NQS3-2]
DR   CCDS; CCDS58843.1; -. [Q9NQS3-3]
DR   PIR; T08732; T08732.
DR   RefSeq; NP_001230215.1; NM_001243286.1. [Q9NQS3-2]
DR   RefSeq; NP_001230217.1; NM_001243288.1. [Q9NQS3-3]
DR   RefSeq; NP_056295.1; NM_015480.2. [Q9NQS3-1]
DR   PDB; 4FOM; X-ray; 3.93 A; A=58-359.
DR   PDBsum; 4FOM; -.
DR   AlphaFoldDB; Q9NQS3; -.
DR   SMR; Q9NQS3; -.
DR   BioGRID; 117441; 84.
DR   CORUM; Q9NQS3; -.
DR   DIP; DIP-41491N; -.
DR   IntAct; Q9NQS3; 49.
DR   MINT; Q9NQS3; -.
DR   STRING; 9606.ENSP00000418070; -.
DR   GlyGen; Q9NQS3; 10 sites, 2 O-linked glycans (3 sites).
DR   iPTMnet; Q9NQS3; -.
DR   PhosphoSitePlus; Q9NQS3; -.
DR   BioMuta; NECTIN3; -.
DR   DMDM; 74762752; -.
DR   EPD; Q9NQS3; -.
DR   jPOST; Q9NQS3; -.
DR   MassIVE; Q9NQS3; -.
DR   MaxQB; Q9NQS3; -.
DR   PaxDb; Q9NQS3; -.
DR   PeptideAtlas; Q9NQS3; -.
DR   PRIDE; Q9NQS3; -.
DR   ProteomicsDB; 20157; -.
DR   ProteomicsDB; 82178; -. [Q9NQS3-1]
DR   ProteomicsDB; 82179; -. [Q9NQS3-2]
DR   Antibodypedia; 2646; 354 antibodies from 35 providers.
DR   DNASU; 25945; -.
DR   Ensembl; ENST00000319792.7; ENSP00000321514.3; ENSG00000177707.11. [Q9NQS3-2]
DR   Ensembl; ENST00000485303.6; ENSP00000418070.1; ENSG00000177707.11. [Q9NQS3-1]
DR   Ensembl; ENST00000493615.5; ENSP00000420579.1; ENSG00000177707.11. [Q9NQS3-3]
DR   GeneID; 25945; -.
DR   KEGG; hsa:25945; -.
DR   MANE-Select; ENST00000485303.6; ENSP00000418070.1; NM_015480.3; NP_056295.1.
DR   UCSC; uc003dxt.3; human. [Q9NQS3-1]
DR   CTD; 25945; -.
DR   DisGeNET; 25945; -.
DR   GeneCards; NECTIN3; -.
DR   HGNC; HGNC:17664; NECTIN3.
DR   HPA; ENSG00000177707; Tissue enhanced (testis).
DR   MIM; 607147; gene.
DR   neXtProt; NX_Q9NQS3; -.
DR   OpenTargets; ENSG00000177707; -.
DR   PharmGKB; PA134969621; -.
DR   VEuPathDB; HostDB:ENSG00000177707; -.
DR   eggNOG; ENOG502QTRU; Eukaryota.
DR   GeneTree; ENSGT00940000156028; -.
DR   HOGENOM; CLU_029618_3_0_1; -.
DR   InParanoid; Q9NQS3; -.
DR   OMA; QMYPLYS; -.
DR   OrthoDB; 509401at2759; -.
DR   PhylomeDB; Q9NQS3; -.
DR   TreeFam; TF331051; -.
DR   PathwayCommons; Q9NQS3; -.
DR   Reactome; R-HSA-418990; Adherens junctions interactions.
DR   Reactome; R-HSA-420597; Nectin/Necl trans heterodimerization.
DR   SignaLink; Q9NQS3; -.
DR   BioGRID-ORCS; 25945; 13 hits in 1074 CRISPR screens.
DR   ChiTaRS; NECTIN3; human.
DR   GeneWiki; PVRL3; -.
DR   GenomeRNAi; 25945; -.
DR   Pharos; Q9NQS3; Tbio.
DR   PRO; PR:Q9NQS3; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9NQS3; protein.
DR   Bgee; ENSG00000177707; Expressed in stromal cell of endometrium and 165 other tissues.
DR   ExpressionAtlas; Q9NQS3; baseline and differential.
DR   Genevisible; Q9NQS3; HS.
DR   GO; GO:0005912; C:adherens junction; IBA:GO_Central.
DR   GO; GO:0043296; C:apical junction complex; IBA:GO_Central.
DR   GO; GO:0044291; C:cell-cell contact zone; IEA:Ensembl.
DR   GO; GO:0005911; C:cell-cell junction; ISS:ARUK-UCL.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; IEA:Ensembl.
DR   GO; GO:0099061; C:integral component of postsynaptic density membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISS:HGNC-UCL.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:HGNC-UCL.
DR   GO; GO:0061951; P:establishment of protein localization to plasma membrane; ISS:ARUK-UCL.
DR   GO; GO:0009566; P:fertilization; IEA:Ensembl.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IBA:GO_Central.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; ISS:HGNC-UCL.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; IEA:Ensembl.
DR   GO; GO:1902414; P:protein localization to cell junction; IEA:Ensembl.
DR   GO; GO:0060042; P:retina morphogenesis in camera-type eye; IEA:Ensembl.
DR   GO; GO:0007286; P:spermatid development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR033319; Nectin-3.
DR   PANTHER; PTHR23277:SF12; PTHR23277:SF12; 1.
DR   Pfam; PF08205; C2-set_2; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane;
KW   Postsynaptic cell membrane; Reference proteome; Repeat; Signal; Synapse;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..57
FT                   /evidence="ECO:0000255"
FT   CHAIN           58..549
FT                   /note="Nectin-3"
FT                   /id="PRO_0000226372"
FT   TOPO_DOM        58..404
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        405..425
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        426..549
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          59..165
FT                   /note="Ig-like V-type"
FT   DOMAIN          170..258
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          269..354
FT                   /note="Ig-like C2-type 2"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22902367"
FT   CARBOHYD        83
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        125
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22902367"
FT   CARBOHYD        186
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22902367"
FT   CARBOHYD        222
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22902367"
FT   CARBOHYD        331
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22902367"
FT   DISULFID        78..148
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        193..246
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        291..338
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..54
FT                   /note="MARTLRPSPLCPGGGKAQLSSASLLGAGLLLQPPTPPPLLLLLFPLLLFSRL
FT                   CG -> MAEGWRWCFVRRTPGLLRGPLLPRSFSGNPR (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046893"
FT   VAR_SEQ         357..549
FT                   /note="DPPTTTTLQPTIQWHPSTADIEDLATEPKKLPFPLSTLATIKDDTIATIIAS
FT                   VVGGALFIVLVSVLAGIFCYRRRRTFRGDYFAKNYIPPSDMQKESQIDVLQQDELDSYP
FT                   DSVKKENKNPVNNLIRKDYLEEPEKTQWNNVENLNRFERPMDYYEDLKMGMKFVSDEHY
FT                   DENEDDLVSHVDGSVISRREWYV -> DVPFKQTSSIAVAGAVIGAVLALFIIAIFVTV
FT                   LLTPRKKRPSYLDKVIDLPPTHKPPPLYEERSPPLPQKDLFQPEHLPLQTQFKEREVGN
FT                   LQHSNGLNSRSFDYEDENPVGEDGIQQMYPLYNQMCYQDRSPGKHHQNNDPKRVYIDPR
FT                   EHYV (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046894"
FT   VAR_SEQ         357..366
FT                   /note="DPPTTTTLQP -> AYNSVASLNC (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017435"
FT   VAR_SEQ         367..549
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017436"
FT   VARIANT         432
FT                   /note="R -> L (in dbSNP:rs15611)"
FT                   /id="VAR_049995"
FT   CONFLICT        251
FT                   /note="P -> Q (in Ref. 4; AAH67808)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        284
FT                   /note="R -> G (in Ref. 2; BAC11404)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        386
FT                   /note="K -> E (in Ref. 4; AAH17572)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        465
FT                   /note="S -> P (in Ref. 5; CAB43256)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        519
FT                   /note="K -> R (in Ref. 5; CAB43256)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        548
FT                   /note="Y -> C (in Ref. 5; CAB43256)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   549 AA;  61002 MW;  6D1104CCB4A9D731 CRC64;
     MARTLRPSPL CPGGGKAQLS SASLLGAGLL LQPPTPPPLL LLLFPLLLFS RLCGALAGPI
     IVEPHVTAVW GKNVSLKCLI EVNETITQIS WEKIHGKSSQ TVAVHHPQYG FSVQGEYQGR
     VLFKNYSLND ATITLHNIGF SDSGKYICKA VTFPLGNAQS STTVTVLVEP TVSLIKGPDS
     LIDGGNETVA AICIAATGKP VAHIDWEGDL GEMESTTTSF PNETATIISQ YKLFPTRFAR
     GRRITCVVKH PALEKDIRYS FILDIQYAPE VSVTGYDGNW FVGRKGVNLK CNADANPPPF
     KSVWSRLDGQ WPDGLLASDN TLHFVHPLTF NYSGVYICKV TNSLGQRSDQ KVIYISDPPT
     TTTLQPTIQW HPSTADIEDL ATEPKKLPFP LSTLATIKDD TIATIIASVV GGALFIVLVS
     VLAGIFCYRR RRTFRGDYFA KNYIPPSDMQ KESQIDVLQQ DELDSYPDSV KKENKNPVNN
     LIRKDYLEEP EKTQWNNVEN LNRFERPMDY YEDLKMGMKF VSDEHYDENE DDLVSHVDGS
     VISRREWYV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2026